Thrombolytic therapy for ischemic stroke secondary to paradoxical embolism in pregnancy: a case report and literature review

Neurologist. 2012 Jan;18(1):44-8. doi: 10.1097/NRL.0b013e31823d7af0.

Abstract

Introduction: Thrombolysis for acute ischemic stroke has been rarely administrated during pregnancy. Paradoxical embolism through a patent foramen ovale (PFO) or pulmonary arteriovenous malformation (AVM) is an identified risk factor for ischemic stroke.

Case report: We report a 24-year-old woman at 11 weeks gestation who developed a sudden onset of dysarthria, hemiparesis, and hemisensory loss. She was diagnosed as having an ischemic stroke in the left middle cerebral artery (MCA) territory. She was treated with intra-arterial recombinant tissue plasminogen activator with subsequent resolution of her neurological deficits. Further workup revealed the presence of a PFO with a large right-to-left shunt. After being put on antithrombotic therapy, she presented again at 13 gestational weeks with a new ischemic infarction in the vertebrobasilar territory. Her PFO was closed percutaneously under ultrasonic guidance but the right-to-left shunt persisted. After a normal delivery, she was found to have a large pulmonary AVM which was successfully resected without complication.

Conclusions: This report describes the successful usage of intra-arterial tissue plasminogen activator for acute ischemic stroke during early pregnancy. In patients with presumed paradoxical embolism, careful attention should be paid to rule out a coexistence of PFO and pulmonary AVM.

Publication types

  • Case Reports
  • Review

MeSH terms

  • Adult
  • Arteriovenous Malformations / complications*
  • Female
  • Foramen Ovale, Patent / complications*
  • Foramen Ovale, Patent / therapy
  • Humans
  • Infarction, Middle Cerebral Artery / complications
  • Infarction, Middle Cerebral Artery / drug therapy*
  • Pregnancy
  • Pregnancy Complications, Cardiovascular / therapy
  • Pregnancy Complications, Hematologic / drug therapy*
  • Pregnancy Trimester, First
  • Pulmonary Artery / abnormalities*
  • Pulmonary Artery / diagnostic imaging
  • Radiography
  • Risk Factors
  • Thrombolytic Therapy
  • Tissue Plasminogen Activator / therapeutic use*
  • Vertebrobasilar Insufficiency / complications
  • Vertebrobasilar Insufficiency / drug therapy

Substances

  • Tissue Plasminogen Activator